• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾 COVID-19 首例 100 例的流行病学特征及其对疫情控制的启示。

Epidemiology of the first 100 cases of COVID-19 in Taiwan and its implications on outbreak control.

机构信息

Taiwan Centers for Disease Control, No. 6, Linsen S. Rd., Jhongjheng District, Taipei, 10050, Taiwan.

College of Medicine, National Taiwan University, No. 1, Sec. 1, Jan-Ai Rd., Taipei, 10617, Taiwan; Expert Advisory Committee of Coronavirus Disease-2019, Taiwan.

出版信息

J Formos Med Assoc. 2020 Nov;119(11):1601-1607. doi: 10.1016/j.jfma.2020.07.015. Epub 2020 Jul 13.

DOI:10.1016/j.jfma.2020.07.015
PMID:32718892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7357534/
Abstract

PURPOSE

To describe the epidemiology and outcome of the first 100 COVID-19 cases in Taiwan.

METHODS

We included the first 100 patients with laboratory-confirmed SARS-CoV-2 infection in Taiwan. Demographic, clinical, epidemiological and laboratory data were extracted from outbreak investigation reports and medical records.

RESULTS

Illness onset of the 100 patients was during January 11 to March 16, 2020. Twenty-nine (29%) had at least one underlying condition and ten (10%) were asymptomatic. Seventy-one were imported, including four clusters. Twenty-nine were locally-acquired, including four clusters. The median days from onset to report was longer in locally-acquired cases (10 vs 3 days). Three patients died (case fatality rate 3%) and all of them had underlying conditions. As of May 13, 2020, 93 had been discharged in stable condition; the median hospital stay was 30 days (range, 10-79 days).

CONCLUSION

The first 100 cases of COVID-19 in Taiwan showed the persistent threat of imported cases from different countries. Even though sporadic locally-acquired disease has been identified, through contact investigation, isolation, quarantine and implementation of social distancing measures, the epidemic is contained to a manageable level with minimal local transmission.

摘要

目的

描述台湾首例 100 例 COVID-19 病例的流行病学和结局。

方法

我们纳入了台湾首例经实验室确诊的 SARS-CoV-2 感染的 100 例患者。从暴发调查报告和病历中提取了人口统计学、临床、流行病学和实验室数据。

结果

100 例患者的发病日期为 2020 年 1 月 11 日至 3 月 16 日。29 例(29%)至少有一个基础疾病,10 例(10%)为无症状感染者。71 例为输入性病例,包括 4 个聚集性病例。29 例为本地感染病例,包括 4 个聚集性病例。本地感染病例的发病至报告中位天数较长(10 天 vs 3 天)。3 例患者死亡(病死率 3%),且均有基础疾病。截至 2020 年 5 月 13 日,93 例患者已出院,病情稳定;中位住院时间为 30 天(范围,10-79 天)。

结论

台湾首例 100 例 COVID-19 病例表明,来自不同国家的输入性病例持续构成威胁。尽管已发现散发性本地传播疾病,但通过接触者调查、隔离、检疫和实施社会疏远措施,疫情得到控制,传播程度较低,处于可管理水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee8/7357534/4b52902ab3cb/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee8/7357534/3c69d8f69c22/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee8/7357534/4b52902ab3cb/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee8/7357534/3c69d8f69c22/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee8/7357534/4b52902ab3cb/gr2_lrg.jpg

相似文献

1
Epidemiology of the first 100 cases of COVID-19 in Taiwan and its implications on outbreak control.台湾 COVID-19 首例 100 例的流行病学特征及其对疫情控制的启示。
J Formos Med Assoc. 2020 Nov;119(11):1601-1607. doi: 10.1016/j.jfma.2020.07.015. Epub 2020 Jul 13.
2
Containing COVID-19 Among 627,386 Persons in Contact With the Diamond Princess Cruise Ship Passengers Who Disembarked in Taiwan: Big Data Analytics.对627386名与在台湾下船的钻石公主号邮轮乘客有接触者中新冠病毒感染情况的大数据分析
J Med Internet Res. 2020 May 5;22(5):e19540. doi: 10.2196/19540.
3
Analysis of Imported Cases of COVID-19 in Taiwan: A Nationwide Study.台湾地区输入性 COVID-19 病例分析:一项全国性研究。
Int J Environ Res Public Health. 2020 May 9;17(9):3311. doi: 10.3390/ijerph17093311.
4
Integrated Hospital Quarantine System against COVID-19.新冠肺炎综合医院隔离系统
Kaohsiung J Med Sci. 2020 May;36(5):380-381. doi: 10.1002/kjm2.12216. Epub 2020 Apr 13.
5
Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan.新冠防控措施对流感活动的间接获益,中国台湾。
Emerg Infect Dis. 2020 Aug;26(8):1928-1930. doi: 10.3201/eid2608.201192. Epub 2020 Apr 27.
6
Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset.接触者追踪评估 COVID-19 在台湾的传播动态及发病前和发病后不同暴露期的风险。
JAMA Intern Med. 2020 Sep 1;180(9):1156-1163. doi: 10.1001/jamainternmed.2020.2020.
7
Clinical laboratory and dispersion pattern of COVID-19 in a family cluster in the social-distancing period.社交距离期间一个家庭聚集性 COVID-19 的临床实验室检查及传播模式
J Infect Dev Ctries. 2020 Sep 30;14(9):987-993. doi: 10.3855/jidc.13580.
8
Responding to COVID-19 in Hong Kong.香港应对新冠疫情。
Hong Kong Med J. 2020 Jun;26(3):164-166. doi: 10.12809/hkmj205101. Epub 2020 Jun 11.
9
Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease.评估社交隔离干预措施在延迟或拉平冠状病毒病流行曲线方面的效果。
Emerg Infect Dis. 2020 Aug;26(8):1740-1748. doi: 10.3201/eid2608.201093. Epub 2020 Apr 28.
10
COVID-19 outbreak prevention by early containment in Shantou, China.中国汕头通过早期遏制措施预防新冠疫情。
J Infect Dev Ctries. 2020 Jul 31;14(7):742-747. doi: 10.3855/jidc.13121.

引用本文的文献

1
Measuring disease burden of dominant variants of COVID-19 in Taiwan.衡量台湾地区新冠病毒优势变异株的疾病负担。
Heliyon. 2024 Apr 18;10(8):e29868. doi: 10.1016/j.heliyon.2024.e29868. eCollection 2024 Apr 30.
2
SARS-CoV-2 Droplet and Airborne Transmission Heterogeneity.严重急性呼吸综合征冠状病毒2型飞沫传播和气溶胶传播的异质性
J Clin Med. 2022 May 6;11(9):2607. doi: 10.3390/jcm11092607.
3
Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis.

本文引用的文献

1
Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset.接触者追踪评估 COVID-19 在台湾的传播动态及发病前和发病后不同暴露期的风险。
JAMA Intern Med. 2020 Sep 1;180(9):1156-1163. doi: 10.1001/jamainternmed.2020.2020.
2
Temporal dynamics in viral shedding and transmissibility of COVID-19.新冠病毒脱落和传播的时间动态。
Nat Med. 2020 May;26(5):672-675. doi: 10.1038/s41591-020-0869-5. Epub 2020 Apr 15.
3
Policy Decisions and Use of Information Technology to Fight COVID-19, Taiwan.
全球检测人群和确诊 COVID-19 人群中无症状 SARS-CoV-2 感染比例的系统评价和荟萃分析。
JAMA Netw Open. 2021 Dec 1;4(12):e2137257. doi: 10.1001/jamanetworkopen.2021.37257.
4
Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.无症状 SARS-CoV-2 感染:系统评价和荟萃分析。
Proc Natl Acad Sci U S A. 2021 Aug 24;118(34). doi: 10.1073/pnas.2109229118.
5
Epidemiology, clinical spectrum, viral kinetics and impact of COVID-19 in the Asia-Pacific region.亚太地区的 COVID-19 流行病学、临床特征、病毒动力学及影响。
Respirology. 2021 Apr;26(4):322-333. doi: 10.1111/resp.14026. Epub 2021 Mar 9.
6
Stay-at-home policy is a case of exception fallacy: an internet-based ecological study.居家政策是一个例外谬误的案例:一项基于互联网的生态学研究。
Sci Rep. 2021 Mar 5;11(1):5313. doi: 10.1038/s41598-021-84092-1.
7
Asthma in patients with coronavirus disease 2019: A systematic review and meta-analysis.2019 冠状病毒病患者的哮喘:系统评价和荟萃分析。
Ann Allergy Asthma Immunol. 2021 May;126(5):524-534. doi: 10.1016/j.anai.2021.02.013. Epub 2021 Feb 18.
8
An Overview of Epidemiology of COVID-19 in Macau S.A.R.澳门特别行政区 COVID-19 流行病学概述
Front Public Health. 2020 Oct 30;8:550057. doi: 10.3389/fpubh.2020.550057. eCollection 2020.
9
Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan.台湾北部 COVID-19 患者的嗅觉障碍和味觉障碍。
J Formos Med Assoc. 2021 Jan;120(1 Pt 2):311-317. doi: 10.1016/j.jfma.2020.10.003. Epub 2020 Oct 20.
10
Incidence of COVID-19 among returning travelers in quarantine facilities: A longitudinal study and lessons learned.隔离设施中返回旅行者的 COVID-19 发病率:一项纵向研究及经验教训。
Travel Med Infect Dis. 2020 Nov-Dec;38:101901. doi: 10.1016/j.tmaid.2020.101901. Epub 2020 Oct 10.
抗击 COVID-19 中的政策决策与信息技术运用:台湾地区案例
Emerg Infect Dis. 2020 Jul;26(7):1506-1512. doi: 10.3201/eid2607.200574. Epub 2020 Jun 21.
4
Clinical Characteristics of Covid-19 in China. Reply.中国新冠病毒肺炎的临床特征。回复
N Engl J Med. 2020 May 7;382(19):1861-1862. doi: 10.1056/NEJMc2005203. Epub 2020 Mar 27.
5
Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts.通过实施强化交通管控捆绑措施阻断 COVID-19 传播:对全球防控工作的影响。
J Microbiol Immunol Infect. 2020 Jun;53(3):377-380. doi: 10.1016/j.jmii.2020.03.011. Epub 2020 Mar 14.
6
Early Introduction of Severe Acute Respiratory Syndrome Coronavirus 2 into Europe.严重急性呼吸综合征冠状病毒 2 在欧洲的早期引入。
Emerg Infect Dis. 2020 Jul;26(7):1567-1570. doi: 10.3201/eid2607.200359. Epub 2020 Mar 20.
7
Middle East respiratory syndrome.中东呼吸综合征。
Lancet. 2020 Mar 28;395(10229):1063-1077. doi: 10.1016/S0140-6736(19)33221-0. Epub 2020 Mar 4.
8
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
9
Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome.疑似严重急性呼吸综合征患者中冠状病毒的病毒脱落模式
Lancet. 2004 May 22;363(9422):1699-700. doi: 10.1016/S0140-6736(04)16255-7.
10
SARS outbreak, Taiwan, 2003.2003年台湾地区严重急性呼吸综合征疫情
Emerg Infect Dis. 2004 Feb;10(2):201-6. doi: 10.3201/eid1002.030515.